ArticleWorld journal of oncology2022

Surrogate Endpoints for Overall Survival in Immune-Oncology Trials of Advanced Gastro-Esophageal Carcinoma.

Yuan Fang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.